Evidence-guided tumour profiling offers new hope for clinicians managing difficult-to-treat cancers

Written on:October 1, 2013
Comments are closed

Data from two studies presented at the 2013 European Cancer Congress (ECC 2013), announced by Caris Life Sciences, demonstrate the potential of evidence-guided tumour profiling to immediately improve the treatment of patients with hard-to-treat cancers, including cancers of unknown primary (CUP) and rarer and refractory cancers…

Source: Medical Devices


Sorry, the comment form is closed at this time.